journal article·2025-01-27

Self-supply of hydrogen peroxide by a bimetal-based nanocatalytic platform to enhance chemodynamic therapy for tumor treatment

Tingxuan Yan, Jiahao Su, Tingyuan Yan, Jinlei Bian, Ahmed R Ali, Wei Yuan, Linping Wei, Yu Wang, Mengting Gao, Qiang Ding, Lei Bi, Shuangshou Wang, Xinya Han

Nanotechnology· Volume 36· Issue 4
Publisher page

Abstract

Abstract The tumor microenvironment (TME) is characterized by low pH, hypoxia, and overexpression of glutathione (GSH). Owing to the complexity of tumor pathogenesis and the heterogeneity of the TME, achieving satisfactory efficacy with a single treatment method is difficult, which significantly impedes tumor treatment. In this study, composite nanoparticles of calcium-copper/alginate-hyaluronic acid (HA) (CaO2-CuO2@SA/HA NC) with pH and GSH responsiveness were prepared for the first time through a one-step synthesis using HA as a targeting ligand. Nanoparticles loaded with H2O2 can enhance the chemodynamic therapy effects. Simultaneously, Cu2+ can generate oxygen in the TME and alleviate hypoxia in tumor tissue. Cu2+ and H2O2 undergo the Fenton reaction to produce cytotoxic hydroxyl radicals and Ca2+ ions, which enhance the localization and clearance of nanoparticles in tumor cells. Additionally, HA and sodium alginate (SA) were utilized to improve the targeting and biocompatibility of the nanoparticles. Fourier transform infrared, x-ray diffraction, dynamic light scattering, SEM, transmission electron microscope, and other analytical methods were used to investigate their physical and chemical properties. The results indicate that the CaO2-CuO2@SA/HA NC prepared using a one-step method had a particle size of 220 nm, a narrow particle size distribution, and a uniform morphology. The hydrogen peroxide self-supplied nanodrug delivery system exhibited excellent pH-responsive release performance and glutathione-responsive •OH release ability while also reducing the level of reactive oxide species quenching. In vitro cell experiments, no obvious side effects on normal tissues were observed; however, the inhibition rate of malignant tumors HepG2 and DU145 exceeded 50%. The preparation of CaO2-CuO2@SA/HA NC nanoparticles, which can achieve both chemokinetic therapy and ion interference therapy, has demonstrated significant potential for clinical applications in cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21492 ↗
2. Sulfonated vitamin K3 mediated bimetallic metal-organic framework for multistage augmented cancer therapy10.1016/j.jcis.2023.10.016 ↗
3. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
4. Glutathione-triggered nanoplatform for chemodynamic/metal-ion therapy10.1039/D1TB01330K ↗
5. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized Fenton reaction10.1002/anie.201510031 ↗
6. Dual-oxygenation/dual-Fenton synergistic photothermal/chemodynamic/starvation therapy for tumor treatment10.1021/acsami.2c22578 ↗
7. Fe-doped nanodiamond-based photo-Fenton catalyst for dual-modal fluorescence imaging and improved chemotherapeutic efficacy against tumor hypoxia10.1039/D3RA08465E ↗
8. Chemodynamic therapy: tumour microenvironment‐mediated Fenton and Fenton‐like reactions10.1002/ange.201805664 ↗
9. Self-assembled copper–amino acid nanoparticles for in situ glutathione “AND” H2O2 sequentially triggered chemodynamic therapy10.1021/jacs.8b08714 ↗
10. Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy10.1021/jacs.9b03457 ↗
11. A smart theranostic prodrug system activated by reactive oxygen species for regional chemotherapy of metastatic cancer10.1002/ange.202116807 ↗
12. Self‐supply of O2 and H2O2 by a nanocatalytic medicine to enhance combined chemo/chemodynamic therapy10.1002/advs.201902137 ↗
13. Nanomedicines and nanomaterials for cancer therapy: progress, challenge and perspectives10.1016/j.cej.2022.137147 ↗
14. Nanomaterials for cancer therapy: current progress and perspectives10.1186/s13045-021-01096-0 ↗
15. Radiation effects on the tumor microenvironment: implications for nanomedicine delivery10.1016/j.addr.2016.05.021 ↗
16. PDD-guided tumor excision combined with photodynamic therapy in patients with extramammary Paget’s disease10.1016/j.pdpdt.2022.102841 ↗
17. Chemodynamic therapy: tumour microenvironment-mediated Fenton and Fenton-like reactions10.1002/ange.201805664 ↗
18. ROS function in redox signaling and oxidative stress10.1016/j.cub.2014.03.034 ↗
19. Reactive oxygen species (ROS)-responsive nanomedicine for solving ischemia-reperfusion injury10.3389/fchem.2020.00732 ↗
20. Multifunctional nanosystems sequentially regulating intratumor Fenton chemistry by remodeling the tumor microenvironment to reinforce chemodynamic therapy10.1016/j.bioadv.2022.212957 ↗
21. Cooperation of endogenous and exogenous reactive oxygen species induced by zinc peroxide nanoparticles to enhance oxidative stress-based cancer therapy10.7150/thno.39831 ↗
22. Simultaneous Fenton‐like ion delivery and glutathione depletion by MnO2‐based nanoagent to enhance chemodynamic therapy10.1002/ange.201712027 ↗
23. Tumor-selective catalytic nanomedicine by nanocatalyst delivery10.1038/s41467-017-00424-8 ↗
24. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment10.1039/C7CS00891K ↗
25. Tumor cells have decreased ability to metabolize H2O2: implications for pharmacological ascorbate in cancer therapy10.1016/j.redox.2016.10.010 ↗
26. Defective Cu2-xSe crystals for ultrasound-enhanced CDT of tumor therapy10.1016/j.ceramint.2022.08.042 ↗
27. A universal nanoreactor triggering butterfly effect for encouraging Fenton/Fenton-like reactions and chemodynamic therapy10.1016/j.jcis.2024.05.091 ↗
28. Development of sludge-derived mesoporous material with loaded nano CaO2 and doped Fe for re-utilization of dewatered waste-activated sludge as dewatering aids10.1016/j.cej.2017.10.015 ↗
29. GSH-responsive polymeric micelles for remodeling the tumor microenvironment to improve chemotherapy and inhibit metastasis in breast cancer10.1021/acs.biomac.3c00523 ↗
30. Redox regulation of cellular signalling10.1016/S0898-6568(98)00037-0 ↗
31. Advances in nanotherapeutics for tumor treatment by targeting calcium overload10.1016/j.colsurfb.2024.114190 ↗
32. Cu0-based nanoparticles boost anti-tumor efficacy via synergy of cuproptosis and ferroptosis enhanced by cuproptosis-induced glutathione synthesis disorder10.1016/j.colsurfb.2024.114196 ↗
33. Anti-liver cancer effects and mechanisms and its application in nano DDS of polysaccharides: a review10.1016/j.ijbiomac.2024.135181 ↗
34. Evaluating the efficiency of hyaluronic acid for tumor targeting via CD4410.1021/acs.molpharmaceut.9b00083 ↗
35. Nanoscale metal–organic frameworks combined with metal nanoparticles and metal oxide/peroxide to relieve tumor hypoxia for enhanced photodynamic therapy10.1021/acsbiomaterials.3c00509 ↗
36. Methods for the in vitro characterization of nanomedicines—biological component interaction10.3390/jpm7010002 ↗
37. Anti-biofilm and anti-hemolysis activities of 10-hydroxy-2-decenoic acid against staphylococcus aureus10.3390/molecules27051485 ↗
38. A drug‐free tumor therapy strategy: cancer‐cell‐targeting calcification10.1002/anie.201601364 ↗
39. Intra-mitochondrial biomineralization for inducing apoptosis of cancer cells10.1039/C7SC05189A ↗
40. Hyaluronic acid functionalized green reduced graphene oxide for targeted cancer photothermal therapy10.1016/j.carbpol.2018.07.066 ↗
41. Construction of Cu/ZIF-67/Prussian blue nanostructures with photothermal-enhanced multizyme activity for cancer therapy10.1021/acsanm.3c01904 ↗
42. A versatile gas-generator promoting drug release and oxygen replenishment for amplifying photodynamic-chemotherapy synergetic anti-tumor effects10.1016/j.biomaterials.2021.120985 ↗
43. Engineering poly (ethylene glycol) nanoparticles for accelerated blood clearance inhibition and targeted drug delivery10.1021/jacs.2c06877 ↗